Search Results - "A. Panoskaltsis-Mortari"

Refine Results
  1. 1

    L‐Selectin Is Dispensable for T Regulatory Cell Function Postallogeneic Bone Marrow Transplantation by Carlson, M. J., Fulton, L. M., Coghill, J. M., West, M. L., Burgents, J. E., Wan, Y., PanoskaltsisMortari, A., Tedder, T. F., Blazar, B. R., Serody, J. S.

    Published in American journal of transplantation (01-12-2010)
    “…In murine models, the adoptive transfer of CD4+/CD25+ regulatory T cells (Tregs) inhibited graft‐versus‐host disease (GvHD). Previous work has indicated a…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Low EGF in myeloablative allotransplantation: association with severe acute GvHD in BMT CTN 0402 by Holtan, S G, Newell, L F, Cutler, C, Verneris, M R, DeFor, T E, Wu, J, Howard, A, MacMillan, M L, Antin, J H, Blazar, B R, Weisdorf, D J, Panoskaltsis-Mortari, A

    Published in Bone marrow transplantation (Basingstoke) (01-09-2017)
    “…Epidermal growth factor (EGF) is a recently described biomarker of acute GvHD (aGvHD). Whether low plasma EGF prior to hematopoietic cell transplantation (HCT)…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    CD47 (integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells by Blazar, B R, Lindberg, F P, Ingulli, E, Panoskaltsis-Mortari, A, Oldenborg, P A, Iizuka, K, Yokoyama, W M, Taylor, P A

    Published in The Journal of experimental medicine (20-08-2001)
    “…Integrin-associated protein (CD47) is a broadly expressed protein that costimulates T cells, facilitates leukocyte migration, and inhibits macrophage scavenger…”
    Get full text
    Journal Article
  12. 12

    Ligation of 4-1BB (CDw137) Regulates Graft-Versus-Host Disease, Graft-Versus-Leukemia, and Graft Rejection in Allogeneic Bone Marrow Transplant Recipients by Blazar, Bruce R, Kwon, Byoung S, Panoskaltsis-Mortari, Angela, Kwak, Kyu B, Peschon, Jacques J, Taylor, Patricia A

    Published in The Journal of immunology (1950) (01-03-2001)
    “…4-1BB is expressed on activated CD4(+) and CD8(+) T cells; its ligand, 4-1BB ligand is expressed on APCs. Despite expression on both T cell subpopulations,…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Sex-Based Differences in Vascular Repair With Bone Marrow Cell Therapy: Relevance of Regulatory and Th2-type Cytokines by Zenovich, A.G, Panoskaltsis-Mortari, A, Caron, G.J, Kolb, A.G, Fremming, R, Nelson, W.D, Taylor, D.A

    Published in Transplantation proceedings (01-03-2008)
    “…Abstract Objectives There are differences in symptoms, risk stratification, and efficacy of pharmacological treatments between men and women with coronary…”
    Get full text
    Journal Article Conference Proceeding
  16. 16

    In situ hybridization with digoxigenin-labeled RNA probes: facts and artifacts by Panoskaltsis-Mortari, A, Bucy, R P

    Published in BioTechniques (01-02-1995)
    “…We have developed an easy, stream-lined yet sensitive protocol for in situ hybridization to mRNA in frozen tissue sections or cytospins using…”
    Get more information
    Journal Article
  17. 17
  18. 18

    3D Bioprinted In Vitro Metastatic Models via Reconstruction of Tumor Microenvironments by Meng, Fanben, Meyer, Carolyn M., Joung, Daeha, Vallera, Daniel A., McAlpine, Michael C., Panoskaltsis‐Mortari, Angela

    Published in Advanced materials (Weinheim) (01-03-2019)
    “…The development of 3D in vitro models capable of recapitulating native tumor microenvironments could improve the translatability of potential anticancer drugs…”
    Get full text
    Journal Article
  19. 19

    Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts by BLAZAR, B. R, TAYLOR, P. A, PANOSKATSIS-MORTARI, A, GRAY, G. S, VALLERA, D. A

    Published in Blood (01-05-1995)
    “…We have developed an in vitro system in which C57BL/6 donor splenocytes are exposed to B10.BR host alloantigens in the context of deficient CD28:B7 signaling…”
    Get full text
    Journal Article
  20. 20

    CD28/B7 interactions are required for sustaining the graft-versus- leukemia effect of delayed post-bone marrow transplantation splenocyte infusion in murine recipients of myeloid or lymphoid leukemia cells by Blazar, BR, Taylor, PA, Boyer, MW, Panoskaltsis-Mortari, A, Allison, JP, Vallera, DA

    Published in The Journal of immunology (1950) (01-10-1997)
    “…Graft-vs-leukemia (GVL) can reduce relapse rates after bone marrow transplantation (BMT). Delayed lymphocyte infusion (DLI) post-BMT can mediate a potent GVL…”
    Get full text
    Journal Article